drugset / Trial / NCT04910815
Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.
RandomizedCrossoverSingle-blindDiagnostic
Summary
The purpose of this study is to determine if the gas-sensing capsule can be used to identify increased numbers and a change of the composition of microbiota or microorganisms in the gut to assess small intestinal dysbiosis
Timeline
- Start
- 2021-07-14
- Primary completion
- 2024-06-01
- Completion
- 2024-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rifaximin | Other / unclassified | 550 g | — |